Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

MLA

Rautenberg, Christina, et al. “Real-World Experience of CPX-351 as First-Line Treatment for Patients with Acute Myeloid Leukemia.” Blood Cancer Journal, vol. 11, no. 10, Oct. 2021, pp. 1–8. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....35864438decc18a47fafd1e0e487be90&authtype=sso&custid=ns315887.

APA

Rautenberg, C., Stölzel, F., Röllig, C., Stelljes, M., Gaidzik, V., Lauseker, M., Kriege, O., Verbeek, M., Unglaub, J. M., Thol, F., Krause, S. W., Hänel, M., Neuerburg, C., Vucinic, V., Jehn, C.-F., Severmann, J., Wass, M., Fransecky, L., Chemnitz, J., … Middeke, J. M. (2021). Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia. Blood Cancer Journal, 11(10), 1–8.

Chicago

Rautenberg, Christina, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena Gaidzik, Michael Lauseker, Oliver Kriege, et al. 2021. “Real-World Experience of CPX-351 as First-Line Treatment for Patients with Acute Myeloid Leukemia.” Blood Cancer Journal 11 (10): 1–8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....35864438decc18a47fafd1e0e487be90&authtype=sso&custid=ns315887.